Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistake
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-020-02503-8
Abstract: The diagnosis of transthyretin cardiac amyloidosis (ATTR-CA) is now literally a million-dollar implication. With the approval of tafamidis (Vyndaqel/ Vyndamax) in 2019, ATTR-CA has become a treatable chronic disease state with potentially life prolonging therapy… read more here.
Keywords: interpretation; million dollar; cardiology; pyp imaging ... See more keywords
Imaging artifact and PYP imaging
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-022-02929-2
Abstract: A 74-year-old white male was referred to the outpatient nuclear clinic by the advanced heart failure team with a history of CAD and HFrEF. Echo/Doppler exam revealed unexplained concentric thickening and an ‘‘apical sparing pattern’’.… read more here.
Keywords: pyp; pyp imaging; imaging artifact; cardiology ... See more keywords
SUV QUANTIFICATION OF 99MTC-PYP IMAGING IN TTR-CARDIAC AMYLOIDOSIS USING A CZT CAMERA: A NEW TOOL IN THE ARMAMENTARIUM
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32230-7
Abstract: Transthyretin (TTR) cardiac amyloidosis (CA) is an increasingly recognized cause of heart failure. Diagnosis of TTR-CA relies on visual and semi-quantitative interpretation of planar 99mTc-PYP imaging. However, new methods that directly quantify PYP uptake may… read more here.
Keywords: pyp imaging; ttr cardiac; 99mtc pyp; cardiac amyloidosis ... See more keywords